Cannabigerolic acid (CBGA) is a precursor to several cannabinoids found in cannabis plants, making it a critical compound in both medicinal and industrial applications. In the pharmaceutical sector, CBGA is studied for its potential therapeutic properties, including anti-inflammatory, analgesic, and neuroprotective effects. It is also being explored for its role in managing conditions like diabetes, cardiovascular diseases, and cancer due to its interaction with the endocannabinoid system.

In the cannabis industry, CBGA is essential for the biosynthesis of major cannabinoids like THC, CBD, and CBC, which are widely used in medical and recreational products. Its role in the plant's metabolic pathway makes it valuable for genetic engineering and breeding programs aimed at enhancing specific cannabinoid profiles. Additionally, CBGA is gaining attention in the development of wellness products, such as supplements and skincare items, due to its potential antioxidant and anti-aging properties. Its versatility and foundational role in cannabinoid production continue to drive research and innovation across various fields.